176 related articles for article (PubMed ID: 29468174)
1. Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2.
Reetz K; Rodríguez-Labrada R; Dogan I; Mirzazade S; Romanzetti S; Schulz JB; Cruz-Rivas EM; Alvarez-Cuesta JA; Aguilera Rodríguez R; Gonzalez Zaldivar Y; Auburger G; Velázquez-Pérez L
Ann Clin Transl Neurol; 2018 Feb; 5(2):128-137. PubMed ID: 29468174
[TBL] [Abstract][Full Text] [Related]
2. Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data.
Jacobi H; Reetz K; du Montcel ST; Bauer P; Mariotti C; Nanetti L; Rakowicz M; Sulek A; Durr A; Charles P; Filla A; Antenora A; Schöls L; Schicks J; Infante J; Kang JS; Timmann D; Di Fabio R; Masciullo M; Baliko L; Melegh B; Boesch S; Bürk K; Peltz A; Schulz JB; Dufaure-Garé I; Klockgether T
Lancet Neurol; 2013 Jul; 12(7):650-8. PubMed ID: 23707147
[TBL] [Abstract][Full Text] [Related]
3. Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study.
Guerrini L; Lolli F; Ginestroni A; Belli G; Della Nave R; Tessa C; Foresti S; Cosottini M; Piacentini S; Salvi F; Plasmati R; De Grandis D; Siciliano G; Filla A; Mascalchi M
Brain; 2004 Aug; 127(Pt 8):1785-95. PubMed ID: 15240431
[TBL] [Abstract][Full Text] [Related]
4. Progression of Cerebellar Atrophy in Spinocerebellar Ataxia Type 2 Gene Carriers: A Longitudinal MRI Study in Preclinical and Early Disease Stages.
Nigri A; Sarro L; Mongelli A; Pinardi C; Porcu L; Castaldo A; Ferraro S; Grisoli M; Bruzzone MG; Gellera C; Taroni F; Mariotti C; Nanetti L
Front Neurol; 2020; 11():616419. PubMed ID: 33384659
[TBL] [Abstract][Full Text] [Related]
5. Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6.
Reetz K; Costa AS; Mirzazade S; Lehmann A; Juzek A; Rakowicz M; Boguslawska R; Schöls L; Linnemann C; Mariotti C; Grisoli M; Dürr A; van de Warrenburg BP; Timmann D; Pandolfo M; Bauer P; Jacobi H; Hauser TK; Klockgether T; Schulz JB;
Brain; 2013 Mar; 136(Pt 3):905-17. PubMed ID: 23423669
[TBL] [Abstract][Full Text] [Related]
6. ADC mapping of neurodegeneration in the brainstem and cerebellum of patients with progressive ataxias.
Della Nave R; Foresti S; Tessa C; Moretti M; Ginestroni A; Gavazzi C; Guerrini L; Salvi F; Piacentini S; Mascalchi M
Neuroimage; 2004 Jun; 22(2):698-705. PubMed ID: 15193598
[TBL] [Abstract][Full Text] [Related]
7. Association of the Level of Neurofilament Light With Disease Severity in Patients With Spinocerebellar Ataxia Type 2.
Yang L; Shao YR; Li XY; Ma Y; Dong Y; Wu ZY
Neurology; 2021 Dec; 97(24):e2404-e2413. PubMed ID: 34706976
[TBL] [Abstract][Full Text] [Related]
8. Regional Brain and Spinal Cord Volume Loss in Spinocerebellar Ataxia Type 3.
Faber J; Schaprian T; Berkan K; Reetz K; França MC; de Rezende TJR; Hong J; Liao W; van de Warrenburg B; van Gaalen J; Durr A; Mochel F; Giunti P; Garcia-Moreno H; Schoels L; Hengel H; Synofzik M; Bender B; Oz G; Joers J; de Vries JJ; Kang JS; Timmann-Braun D; Jacobi H; Infante J; Joules R; Romanzetti S; Diedrichsen J; Schmid M; Wolz R; Klockgether T
Mov Disord; 2021 Oct; 36(10):2273-2281. PubMed ID: 33951232
[TBL] [Abstract][Full Text] [Related]
9. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6.
Schulz JB; Borkert J; Wolf S; Schmitz-Hübsch T; Rakowicz M; Mariotti C; Schöls L; Timmann D; van de Warrenburg B; Dürr A; Pandolfo M; Kang JS; Mandly AG; Nägele T; Grisoli M; Boguslawska R; Bauer P; Klockgether T; Hauser TK
Neuroimage; 2010 Jan; 49(1):158-68. PubMed ID: 19631275
[TBL] [Abstract][Full Text] [Related]
10. [Spinocerebellar ataxias type 1 and 2: comparison of clinical, electrophysiological and magnetic resonance evaluation].
Rakowicz M; Zdzienicka E; Poniatowska R; Waliniowska E; Sułek A; Jakubowska T; Niedzielska K; Rola R; Wierzbicka A; Hoffman-Zacharska D; Głazowski C; Jakubczyk T; Niewiadomska M; Zaremba J
Neurol Neurochir Pol; 2005; 39(4):263-275. PubMed ID: 16096942
[TBL] [Abstract][Full Text] [Related]
11. Heritability of saccadic eye movements in spinocerebellar ataxia type 2: insights into an endophenotype marker.
Rodríguez-Labrada R; Vázquez-Mojena Y; Canales-Ochoa N; Medrano-Montero J; Velázquez-Pérez L
Cerebellum Ataxias; 2017; 4():19. PubMed ID: 29276612
[TBL] [Abstract][Full Text] [Related]
12. Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study.
Velázquez-Pérez L; Rodríguez-Labrada R; Canales-Ochoa N; Montero JM; Sánchez-Cruz G; Aguilera-Rodríguez R; Almaguer-Mederos LE; Laffita-Mesa JM
Lancet Neurol; 2014 May; 13(5):482-9. PubMed ID: 24657153
[TBL] [Abstract][Full Text] [Related]
13. Hypergonadotropic hypogonadism in spinocerebellar ataxia type 2: a case report.
Kwon DY; Park MH
J Sex Med; 2009 Jun; 6(6):1779-1782. PubMed ID: 19473475
[TBL] [Abstract][Full Text] [Related]
14. Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: a study of symptomatic and asymptomatic individuals.
Inagaki A; Iida A; Matsubara M; Inagaki H
Eur J Neurol; 2005 Sep; 12(9):725-8. PubMed ID: 16128876
[TBL] [Abstract][Full Text] [Related]
15. MRI Evidence of Cerebellar and Extraocular Muscle Atrophy Differently Contributing to Eye Movement Abnormalities in SCA2 and SCA28 Diseases.
Politi LS; Bianchi Marzoli S; Godi C; Panzeri M; Ciasca P; Brugnara G; Castaldo A; Di Bella D; Taroni F; Nanetti L; Mariotti C
Invest Ophthalmol Vis Sci; 2016 May; 57(6):2714-20. PubMed ID: 27196319
[TBL] [Abstract][Full Text] [Related]
16. Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics.
Della Nave R; Ginestroni A; Tessa C; Salvatore E; De Grandis D; Plasmati R; Salvi F; De Michele G; Dotti MT; Piacentini S; Mascalchi M
Neuroimage; 2008 Oct; 43(1):10-9. PubMed ID: 18672073
[TBL] [Abstract][Full Text] [Related]
17. Progressive white matter degeneration in patients with spinocerebellar ataxia type 2.
Tu Y; Li Z; Xiong F; Gao F
Neuroradiology; 2024 Jan; 66(1):101-108. PubMed ID: 38040824
[TBL] [Abstract][Full Text] [Related]
18. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study.
Jacobi H; du Montcel ST; Bauer P; Giunti P; Cook A; Labrum R; Parkinson MH; Durr A; Brice A; Charles P; Marelli C; Mariotti C; Nanetti L; Panzeri M; Rakowicz M; Sulek A; Sobanska A; Schmitz-Hübsch T; Schöls L; Hengel H; Baliko L; Melegh B; Filla A; Antenora A; Infante J; Berciano J; van de Warrenburg BP; Timmann D; Szymanski S; Boesch S; Kang JS; Pandolfo M; Schulz JB; Molho S; Diallo A; Klockgether T
Lancet Neurol; 2015 Nov; 14(11):1101-8. PubMed ID: 26377379
[TBL] [Abstract][Full Text] [Related]
19. MRI shows a region-specific pattern of atrophy in spinocerebellar ataxia type 2.
Jung BC; Choi SI; Du AX; Cuzzocreo JL; Ying HS; Landman BA; Perlman SL; Baloh RW; Zee DS; Toga AW; Prince JL; Ying SH
Cerebellum; 2012 Mar; 11(1):272-9. PubMed ID: 21850525
[TBL] [Abstract][Full Text] [Related]
20. Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study.
Goel G; Pal PK; Ravishankar S; Venkatasubramanian G; Jayakumar PN; Krishna N; Purushottam M; Saini J; Faruq M; Mukherji M; Jain S
Parkinsonism Relat Disord; 2011 Aug; 17(7):521-7. PubMed ID: 21600833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
